Effect of antihypertensive drug therapy on short-term heart rate variability in newly diagnosed essential hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 2, 2010, Pages

  Pavithran, Purushothaman ^a   Prakash, E Sankaranarayanan ^b   Dutta, Tarun K ^a   Madanmohan, Trakroo ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b AIMST UNIVERSITY   (Malaysia)

Author keywords

Amlodipine; Atenolol; Autonomic control; Sympathovagal balance

Indexed keywords

AMLODIPINE; ATENOLOL; ENALAPRIL; HYDROCHLOROTHIAZIDE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE;

ADULT; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; ARRHYTHMIA, SINUS; ATENOLOL; ENALAPRIL; FEMALE; HEART RATE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; SINOATRIAL NODE;

EID: 75649149104     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05295.x     Document Type: Article

References (32)

1. Fu Q, Zhang R, Witkowski S et al. Persistent sympathetic activation during chronic antihypertensive therapy. A potential mechanism for long-term morbidity? Hypertension 2005 45 : 1 9.
2. Akselrod S, Gordon D, Ubel FA et al. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science 1981 213 : 220 222.
3. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domaCirculation 1991 84 : 482 492.
4. Heart rate variability: Standards of measurement, physiological interpretation, clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996 93 : 1043 1065.
5. Guzzetti S, Piccaluga E, Casati R et al. Sympathetic predominance in essential hypertension: A study employing spectral analysis of heart rate variability. J. Hypertens. 1988 6 : 711 717.
6. Langewitz W, Rüddel H, Schächinger H. Reduced parasympathetic cardiac control in patients with hypertension at rest and under mental stress. Am. Heart J. 1994 127 : 122 128.
7. Huikuri HV, Ylitalo A, Pikkujamsa SM et al. Heart rate variability in systemic hypertension. Am. J. Cardiol. 1996 77 : 1073 1077.
8. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. Reduced heart rate variability in new onset hypertension. Insights into pathogenesis of hypertension: The Framingham Heart study. Hypertension 1998 32 : 293 297.
9. Prakash ES, Madanmohan T, Sethuraman KR, Narayan SK. Cardiovascular autonomic regulation in subjects with normal blood pressure, high-normal blood pressure and recent-onset hypertension. ClExp. Pharmacol. Physiol. 2005 32 : 488 494.
10. Hamada T, Watanabe M, Kaneda T et al. Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine. J. Hypertens. 1998 16 : 111 118.
11. Ylitalo A, Airaksinen J, Sellin L, Huikuri HV. Effect of combination antihypertensive therapy on baroreflex sensitivity and heart rate variability in systemic hypertension. Am. J. Cardiol. 1999 83 : 885 889.
12. Lefrandt JD, Heitmann J, Sevre K et al. The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: The VAMPHYRE study. Am. J. Hypertens. 2001 14 : 1083 1089.
13. Siche JP, Baguet JP, Fagret D, Tremel F, Gaudemaris R, Mallion J. Effects of amlodipine on baroreflex and sympathetic nervous system activity in mild-to-moderate hypertension. Am. J. Hypertens. 2001 14 : 424 428.
14. Chern CM, Hsu HY, Hu HH, Chen YY, Hsu LC, Chao AC. Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension. J. Cardiovasc. Pharmacol. 2006 47 : 169 174.
15. Malik M. Standard measurement of heart rate variability. In : Malik M, Camm AJ (eds). Dynamic Electrocardiography. Blackwell Futura, New York, 2004 13 22.
16. Tsuji H, Larson MG, Venditti FJ et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart study. Circulation 1996 94 : 2850 2855.
17. Dekker JM, Crow RS, Folsom AR et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes. The ARIC study. Circulation 2000 102 : 1239 1244.
18. Dekker JM, Schouten EG, Klootwijk P et al. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. Am. J. Epidemiol. 1997 145 : 899 908.
19. Salo TM, Kantola I, Voipio-Pulkki L-M, Pelttari L, Viikari JSA. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients: Assessment by spectral analysis of heart rate and blood pressure variability. Eur. J. ClPharmacol. 1999 55 : 191 198.
20. Lindqvist M, Kahan T, Melcher A, Ekholm M, Hjemdahl P. Long term calcium antagonist treatment on human hypertension with mibefradil or amlodipine increases sympathetic nerve activity. J. Hypertens. 2007 25 : 169 175.
21. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 42 : 1206 1252.
22. Richmond W. Use of cholesterol oxidase for assay of total and free cholesterol in serum by continuous-flow analysis. ClChem. 1976 22 : 1579 1588.
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. ClChem. 1972 18 : 499 502.
24. Niskanen JP, Tarvainen MP, Ranta-Aha PO, Karjalainen PA. Software for advanced HRV analysis. Comput. Methods Programs Biomed. 2004 76 : 73 81.
25. Uusitalo AL, Tahvanainen KU, Uusitalo AJ, Rusko HK. Non-invasive evaluation of sympathovagal balance in athletes by time and frequency domain analyses of heart rate and blood pressure variability. ClPhysiol. 1996 16 : 575 588.
26. Lombardo F. Physiological understanding of HRV components. In : Malik M, Camm AJ (eds). Dynamic Electrocardiography. Blackwell Futura, New York, 2004 40 7.
27. Pomeranz B, Macaulay RJB, Caudill MA et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am. J. Physiol. 1985 248 : H151 3.
28. Parati G, Omboni S, Villani A et al. Reproducibility of beat-by-beat blood pressure and heart rate variability. Blood Pressure Monit. 2001 6 : 217 220. (Pubitemid 33116420)
29. Pitzalis MV, Mastropasqua F, Massari F et al. α-Blocker effects on respiratory sinus arrhythmia and baroreflex gain in normal subjects. Chest 1998 114 : 185 191.
30. Taylor JA, Myers CW, Halliwill JA, Seidel H, Eckberg DL. Sympathetic restraint of respiratory sinus arrhythmia: Implications for vagal cardiac tone assessment in humans. Am. J. Physiol. Heart Circ. Physiol. 2001 280 : H2801 14.
31. Neil-Dwyer G, Bartlett J, McAinsh J, Cruickshank JM. β-Adrenoceptor blockers and the blood brain barrier. Br. J. ClPharmacol. 1981 11 : 549 553.
32. Morrison SF. Differential control of sympathetic outflow. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001 281 : R683 98.